Table 4.

Beta Coefficients of the Interaction between Age at Final Menstrual Period and Woman‐Specific Slopes for Lipids in the Segment from 1 to 3 y Post‐FMP Predicting Subclinical Carotid Measures at Visits 12/13

Age At FMP By Early Postmenopause Woman‐Specific Slope	Total Cholesterol		LDL‐Cholesterol		Apolipoprotein B
	β (SE)	P Value	β (SE)	P Value	β (SE)	P Value
Intima media thickness, mm
Model 0	0.00074 (0.00022)	<.001	0.00074 (0.00024)	0.002	0.00092 (0.00028)	0.001
Model 1	0.00063 (0.00021)	0.002	0.00054 (0.00023)	0.018	0.00056 (0.00027)	0.042
Model 2	0.00065 (0.00021)	0.002	0.00056 (0.00023)	0.015	0.00058 (0.00028)	0.036
Adventitial diameter, mm
Model 0	0.00408 (0.00121)	<.001	0.00514 (0.00158)	0.001	0.00514 (0.00158)	0.001
Model 1	0.00339 (0.00112)	0.003	0.00350 (0.00148)	0.018	0.00350 (0.00148)	0.018
Model 2	0.00328 (0.001)	0.004	0.00337 (0.00124)	0.007	0.00349 (0.00148)	0.018
Carotid plaque (≥2)
Model 0	0.00863 (0.00429)	0.044	0.00857 (0.00470)	0.068	0.00890 (0.00564)	0.115
Model 1	0.01110 (0.00458)	0.016	0.01160 (0.00499)	0.020	0.00860 (0.00588)	0.143
Model 2	0.01170 (0.00466)	0.021	0.01250 (0.00509)	0.023	0.00965 (0.0059)	0.105

Model 0: Adjusted for age at FMP and subject‐specific slope for lipid changes during the segment 1–3 y post‐FMP.

Model 1: Model 0 adjusted with V12 age, systolic blood pressure, body mass index, use of blood pressure medication, use of diabetes mellitus medication, and ever stroke/heart attack before V12.

Model 2: Model 1 adjusted with ever smoker and anti‐lipid medications at V12/13.

FMP indicates final menstrual period; and LDL, low‐density lipoprotein.

Bold text indicates p values that are less than .05.